Symptomatic Treatment of Vascular Cognitive Impairment

Trial Profile

Symptomatic Treatment of Vascular Cognitive Impairment

Phase of Trial: Phase II/III

Latest Information Update: 05 May 2016

At a glance

  • Drugs Galantamine (Primary) ; Methylphenidate
  • Indications Vascular dementia
  • Focus Therapeutic Use
  • Acronyms STREAM-VCI
  • Most Recent Events

    • 24 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top